{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T04:28:32Z","timestamp":1726892912939},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,20]]},"DOI":"10.7759\/cureus.69803","type":"journal-article","created":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T16:45:08Z","timestamp":1726850708000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical Challenge: Unusual Presentation of a Macular Hemorrhage Extending From the Internal Limiting Membrane to the Subretinal Space on Optical Coherence Tomography (OCT) in a Patient With Branch Retinal Vein Occlusion (BRVO)"],"prefix":"10.7759","author":[{"given":"Lakshita","family":"Maherda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pulak","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilay R","family":"Dhore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Branch retinal vein occlusion","author":"Cochran ML","year":"2023","unstructured":"Cochran ML, Mahabadi N, Czyz CN. Branch retinal vein occlusion. StatPearls. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.07.017","article-title":"The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia","volume":"117","author":"Rogers S","year":"2010","unstructured":"Rogers S, McIntosh RL, Cheung N, et al.. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology. 2010, 117:313-9.e1. 10.1016\/j.ophtha.2009.07.017","journal-title":"Ophthalmology"},{"key":"ref3","article-title":"Epidemiology of branch retinal vein occlusion and its associated systemic diseases: a review","author":"Wang HH","year":"2020","unstructured":"Wang HH, Lee JH. Epidemiology of branch retinal vein occlusion and its associated systemic diseases: a review. Clin Ophthalmol. 2020,","journal-title":"Clin Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/724780","article-title":"Risk factors for central and branch retinal vein occlusion: a meta-analysis of published clinical data","volume":"2014","author":"Kolar P","year":"2014","unstructured":"Kolar P. Risk factors for central and branch retinal vein occlusion: a meta-analysis of published clinical data. J Ophthalmol. 2014, 2014:724780. 10.1155\/2014\/724780","journal-title":"J Ophthalmol"},{"key":"ref5","article-title":"The role of intravitreal dexamethasone in the management of retinal vein occlusion","volume":"118","author":"Rosenfeld PJ","year":"2011","unstructured":"Rosenfeld PJ, Maturi RK, Shams N. The role of intravitreal dexamethasone in the management of retinal vein occlusion. Ophthalmology. 2011, 118:1430-8.","journal-title":"Ophthalmology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2010.02.022","article-title":"Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study","volume":"117","author":"Brown DM","year":"2010","unstructured":"Brown DM, Campochiaro PA, Singh RP, et al.. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology. 2010, 117:1124-33.e1. 10.1016\/j.ophtha.2010.02.022","journal-title":"Ophthalmology"},{"key":"ref7","article-title":"Ranibizumab versus laser treatment for retinal vein occlusion","volume":"368","author":"Brown DM","year":"2013","unstructured":"Brown DM, Campochiaro PA, Singh RP. Ranibizumab versus laser treatment for retinal vein occlusion. N Engl J Med. 2013, 368:327-36.","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/OPX.0b013e3182504227","article-title":"Foveal avascular zone and its relationship to foveal pit shape","volume":"89","author":"Chui TY","year":"2012","unstructured":"Chui TY, Zhong Z, Song H, Burns SA. Foveal avascular zone and its relationship to foveal pit shape. Optom Vis Sci. 2012, 89:602-10. 10.1097\/OPX.0b013e3182504227","journal-title":"Optom Vis Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.02.014","article-title":"Prevalence and causes of visual impairment and blindness in an urban Indian population: the Singapore Indian Eye Study","volume":"118","author":"Zheng Y","year":"2011","unstructured":"Zheng Y, Lavanya R, Wu R, et al.. Prevalence and causes of visual impairment and blindness in an urban Indian population: the Singapore Indian Eye Study. Ophthalmology. 2011, 118:1798-804. 10.1016\/j.ophtha.2011.02.014","journal-title":"Ophthalmology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.11.031","article-title":"Normal-tension glaucoma or PVL?","volume":"117","author":"Brodsky MC","year":"2010","unstructured":"Brodsky MC. Normal-tension glaucoma or PVL?. Ophthalmology. 2010, 117:640. 10.1016\/j.ophtha.2009.11.031","journal-title":"Ophthalmology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.12.037","article-title":"Re: Chia et\u00a0al.: five-year clinical trial on atropine for the treatment of myopia 2: myopia control with atropine 0.01% eyedrops (Ophthalmology 2016;123:391-9)","volume":"123","author":"Galvis V","year":"2016","unstructured":"Galvis V, Tello A, Parra MM, Rodriguez CJ, Blanco O. Re: Chia et\u00a0al.: five-year clinical trial on atropine for the treatment of myopia 2: myopia control with atropine 0.01% eyedrops (Ophthalmology 2016;123:391-9). Ophthalmology. 2016, 123:e40-1. 10.1016\/j.ophtha.2015.12.037","journal-title":"Ophthalmology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/261525-clinical-challenge-unusual-presentation-of-a-macular-hemorrhage-extending-from-the-internal-limiting-membrane-to-the-subretinal-space-on-optical-coherence-tomography-oct-in-a-patient-with-branch-retinal-vein-occlusion-brvo","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T16:45:10Z","timestamp":1726850710000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/261525-clinical-challenge-unusual-presentation-of-a-macular-hemorrhage-extending-from-the-internal-limiting-membrane-to-the-subretinal-space-on-optical-coherence-tomography-oct-in-a-patient-with-branch-retinal-vein-occlusion-brvo"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,20]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.69803","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,20]]}}}